Literature DB >> 2373298

Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J mice congenic at the Ah Locus.

L S Birnbaum1, M M McDonald, P C Blair, A M Clark, M W Harris.   

Abstract

The acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was examined in male C57BL/6J mice differing only at the Ah locus. Wild type mice (Ahb/b, "b/b") were treated once with 0, 50, 100, 200, 300, and 400 micrograms TCDD/kg po while congenic mice (Ahd/d, "d/d") received a single dose of 0, 400, 800, 1600, 2400, and 3200 micrograms TCDD/kg. Mice were checked daily, weighed twice a week, and those that survived, killed 35 days post-treatment. The LD50 values were 159 and 3351 micrograms/kg for b/b and d/d mice, respectively. Mean time to death was 22 days and was independent of dose and genotype. Decrease in body weight gain was noted in both strains 5 days after treatment and occurred at doses greater than or equal to 100 micrograms/kg in b/b mice and 1600 micrograms/kg in d/d mice. Dose-related increases in liver weight (both absolute and relative to body weight) and decreases in thymus, spleen, testes, and epididymal fat pad weights were observed at 8-24-fold higher doses in d/d than in b/b mice. A dose-related increase in segmented neutrophils was observed in both strains. Serum chemistry values indicated that 8-24X greater doses of TCDD were needed to elevate sorbitol dehydrogenase, alanine aminotransferase, and 5'-nucleotidase and to decrease total and esterified cholesterol in d/d than in b/b mice. Few effects were seen on total bile acids, serum triglycerides, glucose, or nonesterified cholesterol. In the liver, hepatocellular cytomegaly, fatty change, and bile duct hyperplasia occurred in both strains in a dose-related manner, as did thymic and splenic atrophy. Necrosis of germinal epithelium in the testes and edema in the stomach submucosa occurred at acutely toxic doses. These lesions also occurred at doses 8-24X greater in d/d than in b/b mice. Thus, the spectrum of toxicity is independent of the allele at the Ah locus, but the relative dose needed to bring about various acute responses is approximately 8-24X greater in congenic mice homozygous for the "d" allele than for the wild type animals carrying two copies of the "b" gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373298     DOI: 10.1016/0272-0590(90)90175-j

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  13 in total

1.  An Aryl Hydrocarbon Receptor from the Salamander Ambystoma mexicanum Exhibits Low Sensitivity to 2,3,7,8-Tetrachlorodibenzo-p-dioxin.

Authors:  Jenny Shoots; Domenico Fraccalvieri; Diana G Franks; Michael S Denison; Mark E Hahn; Laura Bonati; Wade H Powell
Journal:  Environ Sci Technol       Date:  2015-05-21       Impact factor: 9.028

2.  Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.

Authors:  Kelly A Fader; Rance Nault; Mathew P Kirby; Gena Markous; Jason Matthews; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2017-02-16       Impact factor: 4.219

3.  Aryl hydrocarbon receptors in the frog Xenopus laevis: two AhR1 paralogs exhibit low affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  Jeremy A Lavine; Ashley J Rowatt; Tatyana Klimova; Aric J Whitington; Emelyne Dengler; Catherine Beck; Wade H Powell
Journal:  Toxicol Sci       Date:  2005-06-15       Impact factor: 4.849

4.  The molecular basis for differential dioxin sensitivity in birds: role of the aryl hydrocarbon receptor.

Authors:  Sibel I Karchner; Diana G Franks; Sean W Kennedy; Mark E Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

Review 5.  CYP induction-mediated drug interactions: in vitro assessment and clinical implications.

Authors:  Jiunn H Lin
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

Review 6.  AHR-mediated immunomodulation: the role of altered gene transcription.

Authors:  Nancy I Kerkvliet
Journal:  Biochem Pharmacol       Date:  2008-11-27       Impact factor: 5.858

7.  Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat.

Authors:  Michele La Merrill; David S Baston; Michael S Denison; Linda S Birnbaum; Daniel Pomp; David W Threadgill
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-07       Impact factor: 4.310

8.  Integrated approach for evaluating species and interindividual differences in responsiveness to dioxins and structural analogs.

Authors:  G Clark; A Tritscher; D Bell; G Lucier
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

9.  The mechanism of dioxin toxicity: relationship to risk assessment.

Authors:  L S Birnbaum
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

10.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-elicited effects on bile acid homeostasis: Alterations in biosynthesis, enterohepatic circulation, and microbial metabolism.

Authors:  Kelly A Fader; Rance Nault; Chen Zhang; Kazuyoshi Kumagai; Jack R Harkema; Timothy R Zacharewski
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.